Aprecia Pharmaceuticals Private Limited

Founded in 2017 and headquartered in Uttar Pradesh, India.

2017 | Lucknow, Uttar Pradesh (India) | Active
Last Updated:

Aprecia Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 8 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -13.46%
  • Profit Growth 4.89%
  • Ebitda -150.47%
  • Net Worth 221.84%
  • Total Assets 18.65%

About Aprecia Pharmaceuticals

Aprecia Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 May 2017 (Eight years 8 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.

The Corporate was formerly known as Aminabad Surgical Private Limited. The Company is engaged in the Business Services Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Muneeb Alvi and Mohammad Khan serve as directors at the Company.

Company Details

  • Location

    Lucknow, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U74999UP2017PTC093123

  • Company No.

    093123

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 May 2017

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Business Services
Company report

Aprecia Pharmaceuticals Private Limited

Explore comprehensive data for Aprecia Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Aprecia Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Muneeb Alvi Country flag representing In Director 16-May-2017Current
Mohammad Khan Country flag representing In Additional Director 15-Dec-2023Current

Financial Performance of Aprecia Pharmaceuticals.

Aprecia Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.46% decrease. The company also saw a slight improvement in profitability, with a 4.89% increase in profit. The company's net worth Soared by an impressive increase of 221.84%.

Aprecia Pharmaceuticals revenue growth over time
Aprecia Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-13.46%
Revenue from Operations
-13.47%
Total Assets
18.65%
Profit or Loss
4.89%
Net Worth
221.84%
EBITDA
-150.47%

What is the Ownership and Shareholding Structure of Aprecia Pharmaceuticals?

Unlock access to Aprecia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Aprecia Pharmaceuticals?

Unlock and access historical data on people associated with Aprecia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Aprecia Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aprecia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprecia Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Aprecia Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Aprecia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Aprecia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.

  • Director Appointment

    Mohammad Meesam Khan was appointed as a Additional Director was appointed as a Additional Director on 15 Dec 2023 & has been associated with this company since 1 year 5 months .

  • Director Appointment

    Muneeb Alvi was appointed as a Director was appointed as a Director on 16 May 2017 & has been associated with this company since 8 years 8 days .

  • Company Incorporation

    Aprecia Pharmaceuticals Private Limited was registered on 16 May 2017 with Roc Kanpur & aged 8 years 8 days as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Aprecia Pharmaceuticals Private Limited?

    Aprecia Pharmaceuticals Private Limited was incorporated on 16 May 2017.

  • What is authorized share capital and paid-up capital of Aprecia Pharmaceuticals Private Limited?

    The authorized share capital of Aprecia Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Aprecia Pharmaceuticals Private Limited?

    Currently 2 directors are associated with Aprecia Pharmaceuticals Private Limited.

    • Muneeb Alvi
    • Mohammad Meesam Khan

  • What is the registered address of Aprecia Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Aprecia Pharmaceuticals Private Limited is 005, Grandeur Apartment Building No.6 Dalibagh India, Lucknow, Uttar Pradesh, 226001.

  • What is the corporate identification number (CIN) and company number of Aprecia Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Aprecia Pharmaceuticals Private Limited is U74999UP2017PTC093123 and the company number is 093123 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Aprecia Pharmaceuticals Private Limited?

    The Official website of Aprecia Pharmaceuticals Private Limited is https://www.apreciapharma.in

  • What has been the recent revenue trend for Aprecia Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Aprecia Pharmaceuticals Private Limited has fallen by -13.46%.

  • What change has been observed in the net worth of Aprecia Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Aprecia Pharmaceuticals Private Limited has experienced an upsurge of 221.84%.

  • When was the last Balance Sheet of Aprecia Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Aprecia Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Miscellaneous Business Activities